Absci Corporation (ABSI) vs Vir Biotechnology, Inc. (VIR)
Absci Corporation and Vir Biotechnology, Inc. are both Biotechnology companies. Absci Corporation and Vir Biotechnology, Inc. are of similar size ($1.8B and $1.8B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,495.9% against −62.3%. Vir Biotechnology, Inc. has the higher net margin (−83.0% vs −7,756.4%) and the higher return on invested capital (−39.1% vs −174.7%). Across the 17 metrics below, Vir Biotechnology, Inc. leads on 14 and Absci Corporation on 3.
Valuation
Profitability
| Metric | ABSI | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (8,084.50%) | (92.40%) | 0.00% |
| Net margin | (7,756.37%) | (83.00%) | 0.00% |
| Free cash flow margin | (6,969.83%) | (67.17%) | 0.00% |
| Return on equity | (57.72%) | (26.08%) | (57.72%) |
| Return on assets | (50.57%) | (20.91%) | (49.22%) |
| Return on invested capital | (174.74%) | (39.10%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack